The European Commission (EC), through its Scientific Committee on Consumer Safety (SCCS), is reassessing the safety of hydroxyapatite in its nano form. This reconsideration comes after new information has been provided, which encourages a revisitation of the substance’s status (Bergeson & Campbell, P.C.).
As noted in our March 24, 2023, report, the SCCS’s final assessment of hydroxyapatite (nano), based on the data they had at the time, deemed the substance safe at specific concentrations. These approved concentrations were up to 0.465% in various products and up to ten percent in toothpaste.
This new investigation launched by the EC could have implications for a wide range of firms and manufacturers, particularly within the consumer goods sector, where hydroxyapatite (nano) finds standout usage. It is seen as critical that legal professionals working in corporations and law firms stay informed on this matter to continuously advise their clients and institutions accurately.
However, more data is necessary before any concrete decision can be taken. Therefore, all stakeholders are waiting for the SCCS’s reassessment outcome with bated breath. The hope is that the committee’s results will bring clarity to the subject and map out a course for future adherence to safety standards concerning the usage of hydroxyapatite (nano).
Legal spectators, experts, and professionals worldwide can anticipate more insights on this matter as the investigation progresses and the SCCS releases its final report.